Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RLMD
RLMD logo

RLMD News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

RLMD News

Relmada Therapeutics Q1 2026 Earnings Call Highlights

May 13 2026seekingalpha

Relmada Therapeutics Stock Rises After Piper Sandler Coverage Launch

Mar 24 2026seekingalpha

Relmada Reports 2025 Financials and Clinical Advancements

Mar 20 2026NASDAQ.COM

Relmada Therapeutics Financial Report Analysis

Mar 20 2026Yahoo Finance

Relmada (RLMD) Q4 2025 Earnings Call Transcript

Mar 20 2026NASDAQ.COM

Relmada Therapeutics Q4 Earnings Call Highlights

Mar 19 2026Yahoo Finance

Relmada Therapeutics Q4 Earnings Report Analysis

Mar 19 2026seekingalpha

Xenon and Relmada Surge on Positive Drug Data

Mar 09 2026Yahoo Finance

RLMD Events

No data

No data

RLMD Monitor News

Relmada Secures $160 Million in PIPE Financing

Mar 09 2026

RLMD Earnings Analysis

No Data

No Data

People Also Watch